Addition of leukotriene receptor antagonists to inhaled corticosteroids improved QOL of patients with bronchial asthma surveyed in suburban Tokyo, Japan

Allergology International

Volumn 60, Issue 4, 2011, Pages 473-481

  Ohshima, Nobuharu ^a   Matsui, Hirotoshi ^a   Matsui, Yoshinori ^a   Kawashima, Masahiro ^a   Shimada, Masahiro ^a   Higaki, Naoko ^a   Shoji, Shunsuke ^a   Wada, Hiroo ^b   Fujita, Akira ^c   Watanabe, Hidehiro ^d   Yamaguchi, Norio ^e   Matsuoka, Rokuro ^f   Oki, Kazuhiko ^g   Takahashi, Hisaho ^h   Suzuki, Michiaki ⁱ   Yamazaki, Hiroomi ^j   Yoshizawa, Masafumi ^k   Goto, Hajime ^b  

^a TOKYO NATIONAL HOSPITAL   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN TAMA MEDICAL CENTER   (Japan)

^d TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

^e Yamaguchi Chest Clinic   (Japan)

^f Matsuoka Gastrointestinal Clinic   (Japan)

^g Oki Clinic   (Japan)

^h Takahashi Clinic   (Japan)

ⁱ Showa General Hospital   (Japan)

^j Yamazaki Chest Clinic   (Japan)

^k MUSASHINO RED CROSS HOSPITAL   (Japan)

more..

Author keywords

Bronchial asthma; Inhaled corticosteroids; Leukotriene receptor antagonists; Quality of life; Survey

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; THEOPHYLLINE;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; DISEASE CONTROL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; EMERGENCY WARD; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SLEEP DISORDER; SYMPTOM;

EID: 83455164818     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.10-OA-0296     Document Type: Article

References (18)

1. Bousquet J, Michel FB. International consensus report on diagnosis and management of asthma. Allergy 1992;47: 129-32.
2. [Annual population survey report from the Ministry of Health, Labour and Welfare of Japan 2008] (in Japanese). Available at: http://www.mhlw.go.jp/toukei/saikin/hw/ji nkou/geppo/nengai08/toukei6.html. Accessed June 3, 2009.
3. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-45.
4. Sumi Y, Hamid Q. Airway remodeling in asthma. Allergol Int 2007;56:341-8.
5. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Lowdose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332-6.
6. Haahtela T, Tuomisto LE, Pietinalho A et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006;61:663-70.
7. Adachi M, Ohta K, Morikawa A, Nishima S. [Asthma insights & reality in Japan 2005]. Arerugi 2006;55:1340-3.
8. Nakazawa T, Dobashi K. Current asthma deaths among adults in Japan. Allergol Int 2004;53:205-9.
9. Ministry of Health and Welfare, Japan. Asthma prevention and management guidelines. Int Arch Allergy Immunol 2000;121 (Suppl 1):1-77.
10. Japanese Society of Allergology. [Asthma Prevention and Management Guideline 2009, Japan]. Tokyo: Kyowa Kikaku, 2009;92-113 (in Japanese).
11. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2009. Available at: http://www.ginasthma.org.
12. Bateman ED, Boushey HA, Bousquet J et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004;170:836-44.
13. Bateman E, Nelson H, Bousquet J et al. Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events. Ann Intern Med 2008;149: 33-42.
14. Peters-Golden M, Henderson WR Jr. Leukotrienes. N Engl J Med 2007;357:1841-54.
15. Bisgaard H, Zielen S, Garcia-Garcia ML et al. Montelukast reduces asthma exacerbations in 2-to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 2005; 171:315-22.
16. Johnston NW, Mandhane PJ, Dai J et al. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy. Pediatrics 2007;120:e702-12.
17. Robertson CF, Price D, Henry R et al. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am J Respir Crit Care Med 2007;175:323-9.
18. Bjermer L. Time for a paradigm shift in asthma treatment: from relieving bronchospasm to controlling systemic inflammation. J Allergy Clin Immunol 2007;120:1269-75.